Time-kill profiles of Enterococcus to antibiotics used for intravitreal therapy

Ophthalmic Surgery and Lasers

Volumn 29, Issue 4, 1998, Pages 295-299

  Kowalski, Regis P ^a,b   Karenchak, Lisa M ^a   Warren, Brent B ^a   Eller, Andrew W ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b University of Pittsburgh School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CEFAZOLIN; CIPROFLOXACIN; GENTAMICIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; ENDOPHTHALMITIS; ENTEROCOCCUS FAECALIS; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; DRUG THERAPY, COMBINATION; ENDOPHTHALMITIS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; HUMANS; MICROBIAL SENSITIVITY TESTS; VITREOUS BODY;

EID: 0031948248     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Choi S, Hahn TW, Osterhout G, O'Brien TP. Comparative intravitreal antibiotic therapy for experimental Enterococcus faecalis endophthalmitis. Arch Ophthalmol. 1996;114:61-65.
2. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infections. Am J Med. 1991;91(suppl):72S-75S.
3. Murray BE. The life and times of the enterococcus. Clin Microbiol Rev. 1990;3:46-65.
4. National Committee for Clinical Laboratory Standards. Methods for Determining Bactericidal Activity of Antimicrobial Agents, 3rd ed, vol. 15. Villanova, PA: National Committee for Clinical Laboratory Standards, 1992.
5. Physician's Desk Reference. Pharmaceutical in Ophthalmology: Antimicrobial Therapy, 23rd ed. Monrvale, NJ: Medical Economics Data Products; 1995:5.
6. Peyman GH, Schulman JA. Drug therapy for endophthalmitis. In: Peyman GH, Schulman JA, eds. Intravitreal Surgery: Principles and Practice. Norwalk: Appleton & Lange; 1994:868.
7. Physician's Desk Reference. For Ophthalmology: Product Information, 21st ed. Montvale, NJ: Medical Economics Data Products; 1993:230.
8. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 3rd ed., vol. 13. Villanova, PA: National Committee for Clinical Laboratory Standards; 1993.
9. Noble CJ. Carriage of group D streptococci in the human bowel. J Clin Pathol. 1978;31:1182-1186.
10. Leclerq RS, Derlot E, Weber M, et al. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob Agents Chemother. 1992;33:13-15.
11. Quintilliani R, Evers S, Courvalin P. The van B gene confers various levels of self-transferable resistance to vancomycin in enterococci. J Infect Dis. 1993;167:1220-1223.
12. Leclerq R, Dutka-Malen S, Duval J, Courvalin P. Vancomycin resistance gene van C is specific to Enterococcus gallinarum. Antimicrob Agents Chemother. 1993;36:2005-2008.
13. Mao LK, Flynn HW, Miller D, Pflugfelder SC. Endophthalmitis caused by streptococcal species. Arch Ophthalmol. 1992;110:798-801.
14. Ejdervik-Lindblad B, Lindberg M, Hakansson EB. Enterococcal endophthalmitis following cataract extraction, treated with ampicillin intravitreally. Acta Ophthalmol. 1992;70:842-843.
15. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122:1-17.
16. Gattis WA, A selected review of antimicrobial concentrations within tissues of the bone, eye, and lung. Antimicrobics and Infectious Diseases Newsletter. 1994;13:75-86.
17. Warren, BB, Kowalski RP, Eller AW, Friberg TR. Time-kill studies of Synercid™ against vanomycin-resistant and endophthalmitis isolates of Enterococcus. Invest Ophthalmol Vis Sci. 1996;37(3 suppl):3554. Abstract.
18. Tripodi MF, Utili R, Rambaldi A, et al. Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci. J Antimicrob Chemother. 1996;37:727-736.
19. Kowalski RP, Karenchak LM, Eller AW. The role of ciprofloxacin in endophthalmitis therapy. Am J Ophthalmol. 1993;116:695-699.
20. Jett BD, Jensen HG, Atkuri RV, Gilmore MS. Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing Enterococcus faecalis strains. Invest Ophthalmol Vis Sci. 1995;36:9-15.
21. Shaarawy A, Grand G, Meredith TA, Ibanez HE. Persistent endophthalmitis after intravitreal antimicrobial therapy. Ophthalmology. 1995;102:382-387.
22. Campochiaro PA, Conway BP. Aminoglycoside toxicity: A survey of retinal specialists. Implication for ocular use. Arch Ophthalmol. 1991;109:946-950.